These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39304614)

  • 1. Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα-mTORC1 signaling pathway.
    Hu F; Yan S; Lin L; Qiu X; Lin X; Wang W
    Mol Cell Biochem; 2024 Sep; ():. PubMed ID: 39304614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway.
    Dindaş F; Güngör H; Ekici M; Akokay P; Erhan F; Doğduş M; Yılmaz MB
    Anatol J Cardiol; 2021 Nov; 25(11):821-828. PubMed ID: 34734816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity.
    Boutagy NE; Feher A; Pfau D; Liu Z; Guerrera NM; Freeburg LA; Womack SJ; Hoenes AC; Zeiss C; Young LH; Spinale FG; Sinusas AJ
    JACC CardioOncol; 2020 Dec; 2(5):774-787. PubMed ID: 33437965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
    Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
    Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of valsartan against doxorubicin-induced cardiotoxicity: Histopathology and metabolomics in vivo study.
    Alhazzani K; Alotaibi MR; Alotaibi FN; Aljerian K; As Sobeai HM; Alhoshani AR; Alanazi AZ; Alanazi WA; Alswayyed M
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22842. PubMed ID: 34273911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPM2 knockdown attenuates myocardial apoptosis and promotes autophagy in HFD/STZ-induced diabetic mice via regulating the MEK/ERK and mTORC1 signaling pathway.
    Hu F; Lin C
    Mol Cell Biochem; 2024 Dec; 479(12):3307-3328. PubMed ID: 38308007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway.
    Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q
    Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
    Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
    Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity
    Hu C; Zhang X; Wei W; Zhang N; Wu H; Ma Z; Li L; Deng W; Tang Q
    Acta Pharm Sin B; 2019 Jul; 9(4):690-701. PubMed ID: 31384530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scutellarin Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Myocardial Fibrosis, Apoptosis and Autophagy in Rats.
    Sun X; Zhou L; Han Y; Yang Q; Li X; Xin B; Chi M; Wang Y; Guo C
    Chem Biodivers; 2023 Jan; 20(1):e202200450. PubMed ID: 36419360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction.
    Shi YJ; Yang CG; Qiao WB; Liu YC; Liu SY; Dong GJ
    Eur J Pharmacol; 2023 Dec; 961():176170. PubMed ID: 37939991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
    Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of Sacubitril/Valsartan on Cardiac Fibrosis and Function in Rats With Experimental Myocardial Infarction Involves Inhibition of Collagen Synthesis by Myocardial Fibroblasts Through Downregulating TGF-β1/Smads Pathway.
    Wu M; Guo Y; Wu Y; Xu K; Lin L
    Front Pharmacol; 2021; 12():696472. PubMed ID: 34135764
    [No Abstract]   [Full Text] [Related]  

  • 15. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
    Zhang QL; Yang JJ; Zhang HS
    Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
    Jing X; Yang J; Jiang L; Chen J; Wang H
    Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sacubitril/valsartan attenuates left ventricular remodeling and improve cardiac function by upregulating apelin/APJ pathway in rats with heart failure].
    Liu HZ; Gao CY; Yuan F; Xu Y; Tian H; Wang SQ; Zhang PF; Shi YN; Wei JJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):690-697. PubMed ID: 35856226
    [No Abstract]   [Full Text] [Related]  

  • 18. Sacubitril/Valsartan Inhibits Cardiomyocyte Hypertrophy in Angiotensin II-Induced Hypertensive Mice Independent of a Blood Pressure-Lowering Effect.
    Tashiro K; Kuwano T; Ideishi A; Morita H; Idemoto Y; Goto M; Suematsu Y; Miura SI
    Cardiol Res; 2020 Dec; 11(6):376-385. PubMed ID: 33224383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction to: Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα-mTORC1 signaling pathway.
    Hu F; Yan S; Lin L; Qiu X; Lin X; Wang W
    Mol Cell Biochem; 2024 Nov; ():. PubMed ID: 39535632
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.
    Li X; Zhu Q; Wang Q; Zhang Q; Zheng Y; Wang L; Jin Q
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):629-640. PubMed ID: 32444995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.